Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies
Status:
Completed
Trial end date:
2014-08-07
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to examine the survival of patients undergoing
partially matched hematopoietic stem cell transplant (HSCT) on a new type of treatment
approach, which has been developed specifically for patients who have evidence of their
disease at the time of transplant. In this research study, a way of strengthening the
response of the donor cells against the disease has been developed. Patients will undergo one
additional day between the two steps of the transplant which may allow their donor's cells to
fight the disease more effectively.
Phase:
Phase 2
Details
Lead Sponsor:
Sidney Kimmel Cancer Center at Thomas Jefferson University Thomas Jefferson University